Company Overview of PamBio Ltd.
PamBio Ltd. operates as a biotechnology company that develops drug therapy for acute bleeding conditions. The product is an anti-fibrinolytic agent is an inactive, mutated Tissue Plasminogen Activator (tPA). The company was founded in 2014 and is based in Nazareth Illit, Israel.
P.O. Box 1252
Nazareth Illit, 17111
Founded in 2014
972 4 609 8600
972 4 656 4129
Key Executives for PamBio Ltd.
Similar Private Companies By Industry
|3PLW Ltd.||Middle East/Africa|
|Accelerated Evolution Biotechnologies Ltd||Middle East/Africa|
|Accellta Ltd.||Middle East/Africa|
|Adante Ltd.||Middle East/Africa|
|Advanced Biotechnology Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact PamBio Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.